# PAH — media coverage

PAH was mentioned 14 times over the last 12 months; pulmonaryhypertensionnews.com alone carried 57% of that coverage. 71% of that coverage was positive and 0% negative. 79% was editorial rather than PR or paid placement.

- Data as of: 2026-10-04 (window: last 365 days)
- Mentions (12 months): 14 (14 all-time)
- Outlets (12 months): 5 in 1 countries
- Average sentiment: +0.464 (71% positive, 0% negative)
- PR / editorial: 3 PR · 11 editorial
- Sector: NGO

## Coverage over time (mentions per month)

| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 0 |
| 2026-01 | 2 |
| 2026-02 | 1 |
| 2026-03 | 0 |
| 2026-04 | 2 |
| 2026-05 | 0 |
| 2026-06 | 1 |
| 2026-07 | 3 |
| 2026-08 | 5 |
| 2026-09 | 0 |
| 2026-10 | 0 |

## Top outlets (12 months)

| Outlet | Mentions |
|---|---|
| pulmonaryhypertensionnews.com | 8 |
| finance.yahoo.com | 3 |
| kitv.com | 1 |
| stocktitan.net | 1 |
| tradingview.com | 1 |

## Share of voice among NGO peers (12 months)

| Brand | Mentions |
|---|---|
| Caritas | 48 |
| GONG | 34 |
| PAH | 14 |
| American Nurses Association | 10 |
| Greenpeace | 8 |
| Bildupphovsrätt i Sverige | 7 |
| Females in Action | 7 |
| SEED | 5 |
| WWF | 5 |
| AMI | 2 |

## Recent coverage

- [Can LQDA's Yutrepia Sustain Growth Amid Fierce PAH Competition? - TradingView](https://www.tradingview.com/news/zacks:9dea87f91094b:0-can-lqda-s-yutrepia-sustain-growth-amid-fierce-pah-competition/) — tradingview.com, 2026-08-31, positive
- [A once-daily pill cut PAH worsening risk 55%; FDA review is underway - Stock Titan](https://www.stocktitan.net/news/UTHR/united-therapeutics-corporation-announces-fda-filing-acceptance-of-tqthu7fvk05x.html) — stocktitan.net, 2026-08-24, positive
- [Heart-lung imaging ratio may predict long-term PAH survival - Pulmonary Hypertension News](https://pulmonaryhypertensionnews.com/news/heart-lung-imaging-ratio-predict-long-term-pah-survival/) — pulmonaryhypertensionnews.com, 2026-08-21, neutral
- [Can Yutrepia's Strong Growth Drive Liquidia's PAH Expansion? - Yahoo Finance](https://finance.yahoo.com/healthcare/articles/yutrepias-strong-growth-drive-liquidias-184000558.html) — finance.yahoo.com, 2026-08-19, positive
- [How People Living With PAH Are Shaping Better Support and Education - KITV](https://www.kitv.com/online_features/health_and_wellness/how-people-living-with-pah-are-shaping-better-support-and-education/article_a5b38837-296c-5992-8907-c20914c59811.html) — kitv.com, 2026-08-12, neutral
- [Study uncovers molecular connections between COVID-19 and PAH - Pulmonary Hypertension News](https://pulmonaryhypertensionnews.com/news/study-uncovers-molecular-connections-covid-19-pah/) — pulmonaryhypertensionnews.com, 2026-07-24, positive
- [Can LQDA's Differentiated PAH Strategy Drive Long-Term Growth? - Yahoo Finance](https://finance.yahoo.com/healthcare/articles/lqdas-differentiated-pah-strategy-drive-123600421.html) — finance.yahoo.com, 2026-07-22, positive
- [Can LQDA's Yutrepia Drive Growth in the Competitive PAH Market? - Yahoo Finance](https://finance.yahoo.com/healthcare/articles/lqdas-yutrepia-drive-growth-competitive-163800935.html) — finance.yahoo.com, 2026-07-13, positive

Data: VoilàIQ, 2026-10-04. Canonical: https://voilaiq.com/brand-catalog/pah